Cargando…

Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies

Detalles Bibliográficos
Autores principales:	Egea, Javier, López-Muñoz, Francisco, Fernández-Capetillo, Oscar, Reiter, Russel J., Romero, Alejandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984144/ https://www.ncbi.nlm.nih.gov/pubmed/35401215 http://dx.doi.org/10.3389/fphar.2022.873197

Ejemplares similares

Editorial: Therapeutic Advances in Melatonin Research
por: López-Muñoz, Francisco, et al.
Publicado: (2022)

Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review
por: Ramos, Eva, et al.
Publicado: (2023)

Promising Antineoplastic Actions of Melatonin
por: Favero, Gaia, et al.
Publicado: (2018)

Lactacystin-induced kidney fibrosis: Protection by melatonin and captopril
por: Repova, Kristina, et al.
Publicado: (2022)

Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular Therapeutics
por: Ramos, Eva, et al.
Publicado: (2023)

Potential of Melatonin as Adjuvant Therapy of Oral Cancer in the Era of Epigenomics
por: Capote-Moreno, Ana, et al.
Publicado: (2019)

Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?
por: Romero, Alejandro, et al.
Publicado: (2020)

Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?
por: Romero, Alejandro, et al.
Publicado: (2021)

Melatonin as a Potential Agent in the Treatment of Sarcopenia
por: Coto-Montes, Ana, et al.
Publicado: (2016)

Melatonin as an Antitumor Agent against Liver Cancer: An Updated Systematic Review
por: Fernández-Palanca, Paula, et al.
Publicado: (2021)

Melatonin as a regulator of apoptosis in leukaemia: molecular mechanism and therapeutic perspectives
por: Mafi, Alireza, et al.
Publicado: (2023)

Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson’s Disease
por: Pérez-Lloret, Santiago, et al.
Publicado: (2021)

Melatonin and Nitrones As Potential Therapeutic Agents for Stroke
por: Romero, Alejandro, et al.
Publicado: (2016)

Altered Expression of DAAM1 and PREP Induced by Cadmium Toxicity Is Counteracted by Melatonin in the Rat Testis
por: Venditti, Massimo, et al.
Publicado: (2021)

Protective Effects of Melatonin Against Zearalenone Toxicity on Porcine Embryos in vitro
por: Xu, Yao, et al.
Publicado: (2019)

Corrigendum: Melatonin and Nitrones As Potential Therapeutic Agents for Stroke
por: Romero, Alejandro, et al.
Publicado: (2017)

Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders
por: Loh, Doris, et al.
Publicado: (2021)

The Multiple Functions of Melatonin: Applications in the Military Setting
por: Gancitano, Giuseppe, et al.
Publicado: (2022)

Melatonin as a potential inhibitory agent in head and neck cancer
por: Yeh, Chia-Ming, et al.
Publicado: (2017)

The Coronavirus Disease 2019 (COVID-19): Key Emphasis on Melatonin Safety and Therapeutic Efficacy
por: Ramos, Eva, et al.
Publicado: (2021)

Melatonin Attenuates Dysregulation of the Circadian Clock Pathway in Mice With CCl(4)-Induced Fibrosis and Human Hepatic Stellate Cells
por: González-Fernández, Bárbara, et al.
Publicado: (2018)

Light, Water, and Melatonin: The Synergistic Regulation of Phase Separation in Dementia
por: Loh, Doris, et al.
Publicado: (2023)

Clinical Uses of Melatonin in Pediatrics
por: Sánchez-Barceló, Emilio J., et al.
Publicado: (2011)

Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved
por: Bastani, Sepideh, et al.
Publicado: (2021)

Melatonin reduces lipid peroxidation and membrane viscosity
por: Reiter, Russel J., et al.
Publicado: (2014)

Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance
por: Loh, Doris, et al.
Publicado: (2022)

Evaluation of the effect of direct-acting antiviral agents on melatonin level and lipid peroxidation in chronic hepatitis C patients
por: El-Mahdy, Nageh Ahmed, et al.
Publicado: (2023)

Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis
por: Reiter, Russel J., et al.
Publicado: (2017)

Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism
por: Tan, Dun-Xian, et al.
Publicado: (2015)

Potentiating the Benefits of Melatonin through Chemical Functionalization: Possible Impact on Multifactorial Neurodegenerative Disorders
por: Galano, Annia, et al.
Publicado: (2021)

Aging-Related Ovarian Failure and Infertility: Melatonin to the Rescue
por: Reiter, Russel J., et al.
Publicado: (2023)

Is melatonin deficiency a unifying pathomechanism of high risk patients with COVID-19?
por: Simko, Fedor, et al.
Publicado: (2020)

Neurotoxins: Free Radical Mechanisms and Melatonin Protection
por: Reiter, Russel J., et al.
Publicado: (2010)

Melatonin as a rational alternative in the conservative treatment of resistant hypertension
por: Simko, Fedor, et al.
Publicado: (2019)

Mechanisms of Melatonin in Alleviating Alzheimer’s Disease
por: Shukla, Mayuri, et al.
Publicado: (2017)

Melatonin and Carbohydrate Metabolism in Plant Cells
por: Arnao, Marino B., et al.
Publicado: (2021)

Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19
por: Loh, Doris, et al.
Publicado: (2022)

Alterations in Lipid Levels of Mitochondrial Membranes Induced by Amyloid-β: A Protective Role of Melatonin
por: Rosales-Corral, Sergio A., et al.
Publicado: (2012)

Non-Excitatory Amino Acids, Melatonin, and Free Radicals: Examining the Role in Stroke and Aging
por: Carretero, Victoria Jiménez, et al.
Publicado: (2023)

Melatonin in Retinal Physiology and Pathology: The Case of Age-Related Macular Degeneration
por: Blasiak, Janusz, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gtoeg0n88oekv9tjcu3qai1ie8